PREVYMIS 240 mg, concentrate for solution for infusion bottle, 12 ml
Active ingredients: LÉTERMOVIR
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottle, 12 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PREVYMIS 240 mg, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 12 ml
- Marketing authorisation holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Sept 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64591854CIP73012725CIP133400930127254Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉTERMOVIRsolution | 240 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.